CTOs on the Move

Foundation for Eden Prairie Schools

www.foundationforepschools.org

 
The Foundation for Eden Prairie Schools is proud to be an integral partner with Eden Prairie Schools. Formed in 1998 as a nonprofit 501(c)(3) organization, the Foundation has awarded over $1 million to fund innovative programs that directly impact stud...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Express Digital Graphics Inc

Express Digital Graphics Inc is a Englewood, CO-based company in the Business Services sector.

Ellicott Dredges

Ellicott Dredges is a Baltimore, MD-based company in the Business Services sector.

Bree Communication

Bree Communication is a Bloomington, IN-based company in the Business Services sector.

Joint Venture Mktng

Joint Venture Mktng is a Lanham, MD-based company in the Business Services sector.

InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428)

InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. InnoCare has strong in-house innovation capabilities, holding multiple foreign and domestic patents with a rich product pipeline target liquid tumors, solid tumors, and autoimmune diseases. Our team has discovered and developed a strong pipeline. InnoCare was co-founded by Professor Shi Yigong, a world-renowned structural biologist, and Dr. Cui Jisong, an outstanding leader in the biopharmaceutical industry. We have over 1000 employees. Our core R&D staff brings rich experience from the worlds top pharmaceutical companies, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, Johnson & Johnson, Bayer, etc. We are a truly global biopharmaceutical company with sites in Beijing, Nanjing, Shanghai, and Guangzhou, Hong Kong and Unites States. On March 23, 2020, InnoCare officially listed on the Hong Kong Stock Exchange (code: 9969). And on Sept. 21, 2023, InnoCare successfully got listed on STAR Board of Shanghai Stock Exchange (code: 688428). Our vision is to become a world-class biopharma leader to address the unmet medical needs globally.